Related Experiment Video
Updated: Jul 10, 2026
09:16
Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
Interferon-beta reduces proteinuria in experimental glomerulonephritis.
Simon C Satchell1, Olena Buchatska, Sarah B Khan
1Academic Renal Unit, University of Bristol, Southmead Hospital, Bristol, UK. s.c.satchell@bristol.ac.uk
Journal of the American Society of Nephrology : JASN
|October 19, 2007
Summary
Interferon-beta (IFN-beta) effectively reduced proteinuria in multiple rat models of kidney injury. This immunomodulatory cytokine may offer therapeutic potential for proteinuric renal diseases by improving glomerular barrier function.
Area of Science:
- Nephrology
- Immunology
- Cell Biology
Background:
- Interferon-beta (IFN-beta) is a cytokine known for its immunomodulatory functions.
- Glomerular injury is a hallmark of various kidney diseases, often leading to proteinuria.
Purpose of the Study:
- To investigate the therapeutic potential of IFN-beta in established rat models of glomerular injury.
- To determine the effects of IFN-beta on proteinuria and kidney histology in experimental nephritis.
- To examine the direct impact of IFN-beta on the barrier properties of human glomerular endothelial cells and podocytes.
Main Methods:
- Three distinct rat models of glomerular injury were utilized: nephrotoxic nephritis, Thy-1 nephritis, and puromycin nephropathy.
- Recombinant rat IFN-beta was administered either at disease induction or after disease establishment.
- Proteinuria, serum creatinine, glomerular macrophage counts, cell proliferation, and glomerular histology were assessed.
- Human glomerular endothelial cells and podocytes were cultured to evaluate the effects of human IFN-beta-1a on barrier function.
Main Results:
- IFN-beta significantly reduced proteinuria in all three rat models, with reductions up to 73%, 66%, and 93% respectively.
- While IFN-beta showed a slight reduction in glomerular macrophages in one model, it did not significantly alter glomerular or tubulointerstitial scarring.
- In cultured cells, IFN-beta-1a enhanced barrier properties by increasing electrical resistance and decreasing albumin passage across endothelial and podocyte monolayers.
Conclusions:
- IFN-beta demonstrates significant anti-proteinuric effects across diverse models of glomerular injury.
- The therapeutic benefits of IFN-beta may stem from direct actions on the cellular components of the glomerular filtration barrier.
- IFN-beta holds promise as a potential therapeutic agent for managing proteinuric kidney diseases.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:25Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
01:20Renal Corpuscle
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
01:16Antihypertensive Drugs: Action of Diuretics
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...